News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Obecure Recruits First Patient In Phase II Obesity Study



1/24/2007 11:33:48 AM

RAMAT GAN, Israel--(BUSINESS WIRE)--Obecure has commenced its first Phase II clinical trial to evaluate the efficacy of the company’s OBE101 drug candidate for weight loss in obese patients. The study is a double-blinded, placebo-controlled dose-ranging study in about 280 subjects over a period of three months. The study will be carried out at 20 medical sites across the U.S.

Read at BioSpace.com


comments powered by Disqus
Obecure
 
 
Obesity

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES